MedTrace Logo

Intravenous Metoclopramide Versus Dexketoprofen Trometamol Versus Metoclopramide+ Dexketoprofen Trometamol in Migraine

NCT04252521 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2024-02-08

No results posted yet for this study

Summary

Acute headache is one of the most common reasons for presentation to the emergency department (ED), accounting for 2-3% of all emergency visits. Migraine is a disorder of the central nervous system characterized by a moderate or severe headache, which is generally associated with nausea and/or sensitivity to light and sound, interfering with daily activities.

Conditions

Interventions

DRUG

metoclopramide

10 mg Metpamid in 100 ml normal saline solution

DRUG

dexketoprofen trometamol

50 mg dexketoprofen trometamol in 100 ml normal saline solution

DRUG

metoclopramide+dexketoprofen trometamol

10 mg metoclopramide+50 mg dexketoprofen trometamol in 100 ml normal saline solution

Sponsors & Collaborators

  • Adiyaman University Research Hospital

    lead OTHER

Principal Investigators

  • Umut Gülaçtı · Adiyaman University of Medical Faculty

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-03
Primary Completion
2020-01-03
Completion
2020-01-03

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04252521 on ClinicalTrials.gov